Journal
CANCER DISCOVERY
Volume 8, Issue 1, Pages 14-16Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2159-8290.CD-17-1295
Keywords
-
Categories
Funding
- National Medical Research Council (NMRC) MOH Healthcare Research Scholarship, Singapore
- Duke-NUS Medical School
- Biomedical Research Council, Agency for Science, Technology and Research
Ask authors/readers for more resources
Gastroesophageal adenocarcinoma (GEA) comprises a myriad of distinct subtypes with significant interpatient, intrapatient, and intratumor heterogeneity. Strategies for tackling molecular heterogeneity will be essential for the success of GEA precision oncology-in this regard, blood-based liquid biopsies may provide broader views of the real-time genomic landscape of this disease, identifying actionable biomarkers and monitoring therapy resistance. (C) 2018 AACR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available